Thoas Fioretos
Research team manager
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
Author
Summary, in English
Key points IL1RAP is overexpressed on candidate AML stem cells and is a promising target for antibody-based therapy.
Department/s
- Division of Molecular Medicine and Gene Therapy
- Division of Clinical Genetics
- Stem Cell Center
- Translational Genomic and Functional Studies of Leukemia
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publishing year
2013
Language
English
Pages
3709-3713
Publication/Series
Blood
Volume
121
Issue
18
Links
Document type
Journal article
Publisher
American Society of Hematology
Topic
- Hematology
Status
Published
Research group
- Translational Genomic and Functional Studies of Leukemia
ISBN/ISSN/Other
- ISSN: 1528-0020